Hot Topics at the 2022 SPD 47th Annual Meeting

The 2022 SPD 47th Annual Meeting kicks off this year on July 8 with welcoming remarks from 4 key opinion leaders in the field of dermatology:

–Anita Haggstrom, MD, FAAD, Associate Professor in the Departments of Dermatology and Pediatrics, Associate Director of the Dermatology Program, Director of the Division of Pediatric Dermatology, Director of the Pediatric Dermatology Fellowship, and Director of the Multidisciplinary Lesion Clinic vascular at Riley Hospital in Indianapolis;

–Esteban Fernandez Faith, MD, assistant professor of pediatrics and dermatology at The Ohio State University and program director of the pediatric dermatology fellowship at Nationwide Children’s Hospital, Columbus, Ohio;

–Jenna Streicher, MD, FAAD, assistant professor in the Department of Dermatology, Division of Pediatric Dermatology at Indiana University School of Medicine in Indianapolis, with advanced research training in biostatistics and clinical epidemiology from the ‘University of Pennsylvania School of Medicine in Philadelphia;

–and Patricia Treadwell, critical advisor to the Dean of Indiana University School of Medicine on Diversity, Equity, and Inclusion; Professor Emeritus of Pediatrics and Professor Emeritus of Dermatology at Indiana University School of Medicine in Indianapolis.

And that’s just the beginning. Intriguing SPD sessions this year include “Capillary Malformations: When to Worry,” led by Maria Garzon, MD, professor of dermatology and pediatrics at Columbia University Vagelos College of Physicians and Surgeons and director of the division of pediatric dermatology At New York. Presbyterian Morgan Stanley Children’s Hospital in New York; “Neurofibromatosis: From Bench to Bedside,” presented by D. Wade Clapp, MD, Professor Richard L. Schreiner, Chairman of the Department of Pediatrics and Professor Emeritus at Indiana University; “Working with Orphan Diseases: Challenges and Opportunities,” by Elena Pope, MD, MSc, Professor in the Department of Pediatrics, University of Toronto; and “JAK Inhibitor Update,” by Ali Jabbari, MD, PhD, associate professor of dermatology at the University of Iowa Hospitals and Clinics in Iowa City.

The meeting concludes July 10 with a year-long review, an overview of the range of pediatric dermatology conditions that are at the forefront in 2022, led by Brandi-Kenner-Bell, MD, assistant professor of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine and Attending Physician, Dermatology, Ann and Robert H. Lurie Children’s Hospital of Chicago.

Lillian L. Pena